Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline Article

Visvanathan, Kala, Hurley, Patricia, Bantug, Elissa et al. (2013). Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline . JOURNAL OF CLINICAL ONCOLOGY, 31(23), 2942-+. 10.1200/JCO.2013.49.3122

Open Access International Collaboration

cited authors

  • Visvanathan, Kala; Hurley, Patricia; Bantug, Elissa; Brown, Powel; Col, Nananda F; Cuzick, Jack; Davidson, Nancy E; DeCensi, Andrea; Fabian, Carol; Ford, Leslie; Garber, Judy; Katapodi, Maria; Kramer, Barnett; Morrow, Monica; Parker, Barbara; Runowicz, Carolyn; Vogel, Victor G; Wade, James L; Lippman, Scott M

sustainable development goals

authors

publication date

  • August 10, 2013

published in

keywords

  • BOWEL PROJECT
  • CARDIOVASCULAR EVENTS
  • CONTINUING OUTCOMES RELEVANT
  • FOLLOW-UP
  • INCLUDING TAMOXIFEN
  • Life Sciences & Biomedicine
  • Oncology
  • POSTMENOPAUSAL WOMEN
  • RANDOMIZED-TRIAL
  • SURGICAL ADJUVANT BREAST
  • Science & Technology
  • TAMOXIFEN PROPHYLAXIS
  • TECHNOLOGY-ASSESSMENT

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 2942

end page

  • +

volume

  • 31

issue

  • 23